Molecular characterization and response to cetuximab in a patient with refractory squamous cell anal carcinoma

被引：11
|
作者：
De Dosso, Sara [1 ]
Martin, Vittoria [2 ]
Zanellato, Elena [2 ]
Frattini, Milo [2 ]
Saletti, Piercarlo [1 ]
机构：
[1] Oncol Inst So Switzerland, CH-6500 Bellinzona, Switzerland
[2] Ist Cantonale Patol, Lab Mol Diagnost, Locarno, Switzerland
来源：
TUMORI | 2010年 / 96卷 / 04期
关键词：
anal cancer; cetuximab; EGFR; K-Ras; METASTATIC COLORECTAL-CANCER; SINGLE-AGENT; PHASE-II; IRINOTECAN; CHEMOTHERAPY;
D O I：
10.1177/030089161009600419
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
There are no standard chemotherapeutic options for patients with squamous cell anal carcinoma, relapsing and progressing on palliative cisplatin-based regimens. Similarly to other malignant conditions, monoclonal antibodies directed against the epidermal growth factor receptor may represent an attractive therapeutic strategy. Here we describe a patient who, based on molecular profile, benefited from the combination of irinotecan and cetuximab. Free full text available at www.tumorionline.it
引用
收藏
页码：627 / 628
页数：2
相关论文
共 50 条
  • [21] Is cetuximab active in patients with cisplatin-refractory squamous cell carcinoma of the head and neck?
    James A Bonner
    Kimberly S Keene
    Nature Clinical Practice Oncology, 2007, 4 : 690 - 691
  • [22] Anal squamous cell carcinoma in a patient with Peutz-Jeghers syndrome
    Mullhaupt, B
    Bauerfeind, P
    Kurrer, MO
    Fried, M
    DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (02) : 273 - 277
  • [23] Squamous cell carcinoma of the anal canal and anal margin
    Chawla, AK
    Willett, CG
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (02) : 321 - +
  • [24] Squamous cell carcinoma of the anal canal
    Morton, Michael
    Melnitchouk, Nelya
    Bleday, Ronald
    CURRENT PROBLEMS IN CANCER, 2018, 42 (05) : 486 - 492
  • [25] SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL
    Martin, F. T.
    Kavanagh, D.
    Waldron, R.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2009, 7 (04): : 232 - 237
  • [26] Chemoradiotherapy for anal squamous cell carcinoma
    Houlihan, Orla A.
    O'Neill, Brian D. P.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2016, 14 (04): : 202 - 212
  • [27] Squamous Cell Carcinoma of the Anal Canal
    Zaleski, Lisa
    Turiansky, George W.
    CUTIS, 2010, 85 (03): : 143 - 145
  • [28] Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
    Trilla-Fuertes, Lucia
    Ghanem, Ismael
    Maurel, Joan
    G-Pastrian, Laura
    Mendiola, Marta
    Pena, Cristina
    Lopez-Vacas, Rocio
    Prado-Vazquez, Guillermo
    Lopez-Camacho, Elena
    Zapater-Moros, Andrea
    Heredia, Victoria
    Cuatrecasas, Miriam
    Garcia-Alfonso, Pilar
    Capdevila, Jaume
    Conill, Carles
    Garcia-Carbonero, Rocio
    Heath, Karen E.
    Ramos-Ruiz, Ricardo
    Llorens, Carlos
    Campos-Barros, Angel
    Gamez-Pozo, Angelo
    Feliu, Jaime
    Fresno Vara, Juan Angel
    TRANSLATIONAL ONCOLOGY, 2020, 13 (07):
  • [29] Squamous cell carcinoma of the anal canal
    Rousseau, DL
    Thomas, CR
    Petrelli, NJ
    Kahlenberg, MS
    SURGICAL ONCOLOGY-OXFORD, 2005, 14 (03): : 121 - 132
  • [30] Research on Anal Squamous Cell Carcinoma
    Jethwa, Krishan R.
    Hallemeier, Christopher L.
    CANCERS, 2022, 14 (01)
12345